Latest / Philadelphia News Today | 2 Min News | The Daily News Now!
Breakthrough Drug Extends Pancreatic Cancer Survival | Philadelphia News
FDA just approved daraxonrasib, a game-changing drug for advanced pancreatic cancer, doubling survival time from six to thirteen months in trials — the first treatment ever to extend life for metastatic cases. Patients like April Holmes, once given months to live, now see hope for family moments and travel. Doctors call it a decade-defining breakthrough, with potential to unlock years of extra life as research advances. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.